Recombinant Clostridium botulinum Methylthioribose-1-phosphate isomerase (mtnA)

Shipped with Ice Packs
In Stock

Description

Enzymatic Function and Mechanism

MtnA catalyzes the reversible isomerization of methylthio-d-ribose-1-phosphate (MTR1P) to methylthio-d-ribulose-1-phosphate (MTRu1P). This reaction is critical for methionine recycling, enabling organisms to salvage sulfur and carbon groups from methylthioadenosine . Key mechanistic features include:

  • Substrate specificity: MtnA acts on phosphorylated substrates, distinguishing it from classical aldose-ketose isomerases that require non-phosphorylated, ring-opened aldehydes .

  • Catalytic mechanism: Kinetic isotope effect studies suggest a concerted proton transfer between C1 and C2 of MTR1P during isomerization, bypassing the need for a free aldehyde intermediate .

Recombinant Production Challenges

While recombinant MtnA from Desulfotomaculum reducens and B. subtilis is commercially available , producing C. botulinum MtnA poses unique challenges:

  • Expression systems: C. botulinum is a spore-forming anaerobe requiring specialized culture conditions, unlike model hosts like E. coli .

  • Toxin interference: Co-expression with botulinum neurotoxins (BoNTs) necessitates stringent biocontainment and purification protocols .

Recent advances in CRISPR-Cas9 genome editing for C. botulinum Group II strains could facilitate targeted mtnA knockouts or overexpression, enabling functional studies.

Applications and Research Gaps

  • Biotechnological potential: Engineering MtnA for enhanced activity could optimize methionine recycling in industrial fermentations .

  • Therapeutic relevance: Methionine salvage is a target for antimicrobial development, though C. botulinum-specific inhibitors remain unexplored .

Future Directions

Critical research needs include:

  • Structural characterization: Solving C. botulinum MtnA’s crystal structure to identify species-specific active-site modifications .

  • In vivo validation: Assessing MtnA’s role in C. botulinum pathogenicity using CRISPR-Cas9-engineered strains .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
drdI; CBO1268; CLC_13065-deoxyribose 1-phosphate isomerase; EC 5.3.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-349
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Target Names
mtnA
Target Protein Sequence
MAELLAIKWD DNRDKLILLD QTILPNKIEY IEYDTAEGVY DSIKDMIVRG APAIGVTAAY GLYFAAKVAP EDKFENFFKY LKEKSSYLDS SRPTAVNLSW ALKVMESKAL ENKDKDVKEI KSILREEAKR IHEEDIEICK TIGENLITLL KDGVGILTHC NAGQLATSKY GTATSPMYLA KEKGWNFKVY SDETRPRLQG STLTALELYE AGIDVTTITD NMAAMVMSQG KIDAVIVGCD RIAANGDTAN KIGTMGVSIL AKYFGIPMYI AAPTPSIDIN TKTGEDIPIE ERNPEEVTSR FGVWTAPKGV KVYNPGFDVT PHENITAIVT EKGIVYPPFK ENLKKLFEK
Uniprot No.

Target Background

Function
Catalyzes the isomerization of 5-deoxy-alpha-D-ribose 1-phosphate to 5-deoxy-D-ribulose 1-phosphate. This is part of a 5-deoxyribose salvage pathway that recycles this toxic radical SAM enzyme by-product into common metabolites.
Database Links

KEGG: cbh:CLC_1306

Protein Families
EIF-2B alpha/beta/delta subunits family, MtnA subfamily

Q&A

What is the role of Methylthioribose-1-phosphate isomerase (mtnA) in Clostridium botulinum metabolism?

Methylthioribose-1-phosphate isomerase (mtnA) plays a crucial role in the methionine salvage pathway in Clostridium botulinum, particularly in sulfur metabolism. This enzyme is part of larger microbial gene clusters (MGCs) involved in methyl-sulfur metabolism. Based on genomic analysis, mtnA functions within a network of genes involved in sulfur metabolism, including methionine aminotransferases, sulfurtransferases, and methionine transporters . The enzyme catalyzes the isomerization of methylthioribose-1-phosphate, a key step in recycling sulfur-containing metabolites, which is essential for bacterial survival under certain conditions.

How does mtnA relate to the genetic diversity of Clostridium botulinum strains?

The genetic diversity of Clostridium botulinum is well-established, with strains being categorized into four distinct metabolic/biochemical groups that represent separate species . While specific information about mtnA variation across strains is limited, the gene likely exhibits polymorphisms that correlate with these established groupings. Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) techniques used to differentiate C. botulinum strains could potentially identify variations in or around the mtnA gene locus . Researchers should consider strain-specific genetic contexts when studying mtnA function, as these differences may influence enzyme activity and regulation.

What expression systems are most effective for producing recombinant C. botulinum mtnA?

While there is no specific information about mtnA expression in the available literature, effective approaches for expressing recombinant C. botulinum proteins include:

  • Viral vector systems: Recombinant adeno-associated virus (rAAV) has been successfully used to express C. botulinum-related proteins, suggesting this could be adapted for mtnA expression .

  • Bacterial expression systems: Traditional E. coli expression systems with appropriate tags (His, MBP, GST) are commonly used for recombinant expression of bacterial proteins.

  • Codon optimization: Given the different codon usage between Clostridium and common expression hosts, codon optimization is recommended to improve expression levels.

The choice of expression system should be guided by the intended application (structural studies, enzymatic assays, or antibody production).

How can structural analysis of mtnA contribute to understanding sulfur metabolism in C. botulinum?

Structural analysis of mtnA would reveal critical insights into its catalytic mechanism and substrate specificity. The enzyme's active site configuration would illuminate how it recognizes and processes methylthioribose-1-phosphate. Homology modeling approaches, similar to those used for methyltransferases in C. ljungdahlii MGCs , could predict the structure if crystallographic data is unavailable.

Understanding the structural features of mtnA would:

  • Identify conserved catalytic residues across different strains

  • Reveal potential allosteric regulation sites

  • Provide insights into protein-protein interactions within the methionine salvage pathway

  • Enable rational design of inhibitors for studies of metabolic pathway disruption

What is the relationship between mtnA and cold shock response in C. botulinum?

Analysis of Clostridium botulinum ATCC 3502 cold shock response has been documented , although specific effects on mtnA expression are not detailed in the available literature. Temperature stress typically triggers global metabolic changes, and enzymes involved in sulfur metabolism may be differentially regulated during cold shock. A methodological approach to investigate this relationship would include:

  • Comparative transcriptomics of C. botulinum cultures under normal and cold shock conditions

  • Western blot analysis of mtnA protein levels at different temperatures

  • Enzyme activity assays at various temperatures to characterize the thermal stability profile

  • Construction of reporter strains with the mtnA promoter region to monitor expression under different conditions

How does mtnA function within microbial gene clusters (MGCs) in C. botulinum?

Microbial gene clusters in C. botulinum reveal that mtnA operates within a coordinated network of genes involved in sulfur metabolism. These MGCs (designated as "type 1 MGCs") typically contain methyltransferases (Mlps) categorized into distinct phylogenetic clusters (Mlps1, Mlps2, and Mlps3) . The genes in these clusters encode functions related to methyl-sulfur metabolism, including:

  • Methionine aminotransferases

  • Sulfurtransferases

  • Methionine transporters

  • MarHDK enzymes that catalyze C–S bond cleavage

A methodological approach to study mtnA's role in these clusters would include:

  • Comparative genomic analysis across C. botulinum strains

  • Transcriptional analysis to identify co-regulated genes

  • Protein-protein interaction studies to identify functional complexes

  • Metabolic flux analysis using isotope-labeled precursors

What methods can differentiate between mtnA and other isomerases in experimental settings?

Differentiating mtnA activity from other isomerases requires specific experimental approaches:

  • Substrate specificity assays: Design assays using methylthioribose-1-phosphate as the specific substrate

  • Inhibitor profiling: Develop selective inhibitors based on structural differences between isomerases

  • Antibody-based detection: Generate specific antibodies against unique epitopes in mtnA

  • Genetic approaches: Create knockout strains to confirm enzymatic activity attribution

  • Mass spectrometry: Identify reaction products specific to mtnA catalysis

These approaches should be combined with appropriate controls to ensure specificity in complex cellular extracts.

How can genetic tools be optimized for studying mtnA in C. botulinum?

Genetic manipulation of C. botulinum requires specialized approaches due to its anaerobic nature and varying transformation efficiencies across strains. For studying mtnA:

  • Strain selection: Choose strains with established genetic tools, considering the four distinct metabolic groups

  • Promoter selection: Use native promoters or those proven effective in Clostridium species

  • MLVA application: Adapt Multiple-Locus Variable-Number Tandem-Repeat Analysis techniques to study genetic variations in the mtnA locus across strains

  • Gene knockout strategies: Design constructs that account for potential polar effects on neighboring genes in the MGC

What are the challenges in purifying active recombinant mtnA from C. botulinum?

Purification of active recombinant mtnA presents several challenges that must be addressed methodologically:

  • Oxygen sensitivity: As C. botulinum is an obligate anaerobe, its proteins may be oxygen-sensitive, requiring purification under anaerobic conditions

  • Solubility issues: Fusion tags (MBP, SUMO) may improve solubility

  • Cofactor requirements: Identify and include necessary cofactors during purification and storage

  • Activity verification: Develop specific activity assays that can differentiate between properly folded and misfolded protein

How can researchers assess the potential relationship between mtnA function and botulinum neurotoxin production?

While direct evidence linking mtnA to botulinum neurotoxin (BoNT) production is not presented in the available literature, methodological approaches to investigate this relationship would include:

  • Comparative genomics: Analyze the genomic context of mtnA across toxigenic and non-toxigenic strains

  • Metabolic engineering: Create mtnA knockouts or overexpression strains and measure toxin production

  • Metabolomics: Profile sulfur-containing metabolites in wild-type vs. mtnA-modified strains during toxin production

  • Transcriptional analysis: Investigate co-regulation patterns between mtnA and neurotoxin genes under various conditions

What analytical techniques are most suitable for studying mtnA enzymatic activity?

TechniqueApplicationAdvantagesLimitations
Spectrophotometric assaysReal-time monitoring of isomerase activitySimple, continuous measurementMay lack specificity
Coupled enzyme assaysLinking mtnA activity to measurable outputAmplifies signalPotential interference from coupling enzymes
NMR spectroscopyDirect observation of substrate-to-product conversionProvides structural informationRequires larger amounts of material
Mass spectrometryIdentification of reaction productsHighly sensitive and specificTypically end-point rather than continuous
Isothermal titration calorimetryThermodynamic parameters of substrate bindingDirect measurement of binding affinityRequires purified components

How can strain typing methods be applied to correlate mtnA variants with C. botulinum diversity?

The genetic diversity of C. botulinum strains has been well-characterized through various typing methods . To correlate mtnA variants with established strain classifications:

  • Sequence analysis: Compare mtnA sequences across the four metabolic groups of C. botulinum

  • MLVA application: Multiple-Locus Variable-Number Tandem-Repeat Analysis can identify strain-specific variations

  • SNP analysis: Identify single nucleotide polymorphisms in mtnA that correlate with established strain groupings

  • Phylogenetic analysis: Construct phylogenetic trees based on mtnA sequences compared to whole-genome phylogeny

What protection measures should researchers implement when working with recombinant C. botulinum proteins?

Although recombinant mtnA itself is not a toxin, work with C. botulinum requires strict safety considerations due to potential toxin exposure:

  • Biosafety levels: Work should be conducted in appropriate containment facilities (typically BSL-2 for recombinant proteins, BSL-3 for live organisms)

  • Toxin neutralization: When working with strains that produce BoNT, researchers should have access to antitoxin preparation

  • Vaccination: Personnel may benefit from immunization with recombinant antibody approaches similar to those described for BoNT protection

  • Strain selection: Use attenuated or non-toxigenic strains when possible for recombinant protein work

How should researchers interpret conflicting data regarding mtnA function across different C. botulinum strains?

When encountering conflicting data about mtnA function across strains, consider:

  • Strain-specific differences: The four metabolic groups of C. botulinum represent distinct species with potentially different metabolic networks

  • Experimental conditions: Growth conditions, media composition, and environmental stressors can affect enzyme activity

  • Genetic context: The composition of MGCs containing mtnA may vary across strains

  • Evolutionary adaptations: Different ecological niches may have driven functional diversification of mtnA

Methodological approaches to resolve conflicts include:

  • Side-by-side comparative studies under identical conditions

  • Cross-complementation experiments between strains

  • Detailed biochemical characterization of purified enzymes from different strains

What experimental controls are essential when studying recombinant mtnA activity?

Essential controls for mtnA activity studies include:

  • Enzyme-free controls: Assess non-enzymatic conversion of substrates

  • Heat-inactivated enzyme: Confirm activity loss with denaturation

  • Catalytic mutants: Site-directed mutagenesis of predicted catalytic residues

  • Substrate specificity controls: Test related but non-canonical substrates

  • Strain background controls: Compare wild-type, knockout, and complemented strains

These controls ensure that observed activities are specifically attributed to functional mtnA.

How might mtnA be targeted for development of novel anti-C. botulinum strategies?

While direct antimicrobial strategies targeting mtnA are not discussed in the available literature, methodological approaches could include:

  • Structure-based inhibitor design: Using structural information to design specific inhibitors of mtnA

  • Metabolic bypassing: Supplying alternative sulfur sources that bypass the need for mtnA function

  • Gene silencing approaches: Developing RNA interference strategies to downregulate mtnA expression

  • Immunological targeting: Creating antibodies against surface-exposed regions of mtnA if it has membrane association

The development of protective antibodies against BoNT using viral vector expression systems provides a model for immunological approaches that could be adapted for metabolic targets.

What emerging technologies could advance our understanding of mtnA function in C. botulinum?

Emerging technologies with potential applications include:

  • CRISPRi systems: For tunable repression of mtnA expression without complete knockout

  • Single-cell metabolomics: To understand cell-to-cell variability in methionine metabolism

  • Protein structure prediction using AI: Tools like AlphaFold2 for accurate structural models of mtnA

  • Nanopore sequencing: For rapid identification of mtnA variants across environmental isolates

  • Microfluidic cultivation: For high-throughput screening of growth conditions affecting mtnA expression

These technologies could overcome current limitations in studying anaerobic pathogens like C. botulinum.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.